
Speculation to Selectivity: Renewed Optimism Emerges Across Cannabis and Biotech Plays
Tilray Tilray has enjoyed a series of significant bumps in stock price over the last couple of weeks, driven largely

Tilray Tilray has enjoyed a series of significant bumps in stock price over the last couple of weeks, driven largely

Denmark has officially passed legislation which will solidify its long-running medical cannabis pilot programme as a permanent fixture of its national healthcare system in what has been described as a ‘victory for patients’.

UK-based cannabinoid pharmaceutical company Ananda Pharma has received ethics approval for a Phase 1 clinical study for its lead compound in Australia.

Stenocare Danish medical cannabis oil producer Stenocare has exited its cultivation facility in Denmark, just four years after it was

Argent BioPharma Argent Biopharma (previously MGC Pharmaceuticals) has completed a US$4.5 million capital raise to support its drug development

Argent Biopharma Argent Biopharma (previously MGC Pharmaceuticals), the first company in history to launch an IPO on the London

Hellenic Dynamics Hellenic Dynamics is facing down its second petition for compulsory liquidation this year as it continues to endure

Denmark’s six-year medical cannabis pilot scheme could soon be expanded into a fully legalised market, following a surprise announcement from the government last week.

Cannabis stocks plunge on election results As the outcome of the US presidential election and numerous state-specific cannabis ballots dripped

Voyager Life Voyager Life, which recently rebranded as Mendell Helium, has announced the sale of its cannabis-facing business after
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.